Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, Interchange of vaccine products, SARS-CoV-2 test
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; Johnson and Johnson Dose Number: 1, Moderna Dose Number: 2, Pfizer / BioNTech Dose Number: 3;  Language reporting type  Report about covid treatment: Yes  Reporter type: Patient Gender: Male  Patient occupation: None of the above If vaccine received: Yes Other medication in 2weeks: No  Anti viral details: Product: COVID 19 Treatment  Covid vaccine details : vaccine brand: Pfizer / BioNTech, vaccine brand unknown: False, vaccine administration date: 08Sep2022, vaccine lot unknown: True, vaccine lot unknown reason: Other, vaccine lot unknown reason other: It was the bivalent vaccine, I don't know more specific information., vaccine dose number: 3, vaccine dose number unknown: False, vaccine location: Left arm,  vaccine brand: Other, vaccine brand other: Moderna, vaccine brand unknown: False, vaccine lot unknown: True, vaccine lot unknown reason: Not available/provided to reporter at the time of report completion, vaccine dose number: 2, vaccine dose number unknown: False,  vaccine brand: Other, vaccine brand other: Johnson and johnson,  vaccine brand unknown: False, vaccine lot unknown: True, vaccine lot unknown reason: Not available/provided to reporter at the time of report completion, vaccine dose number: 1, vaccine dose number unknown: False  Adverse event: Symptoms and positive test result 6 days after completing medication and a negative test result.  Adverse event  Adverse event start date: 27Feb2023 Ae resulted in: [None of the above] If patient recovered: Not recovered If treatment ae: No  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.   This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Sep2022 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunization; elasomeran (MODERNA COVID-19 VACCINE), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunization; coviD-19 vaccine nrvv ad26 (jnj 78436735) (JANSSEN COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Johnson and Johnson Dose Number: 1, Moderna Dose Number: 2, Pfizer / BioNTech Dose Number: 3". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: negative test result; Positive, notes: positive test result 6 days. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.